2 analysts have polar opposite views of St. Jude Medical’s Durata ICD lead
St. Jude Medical (NYSE:STJ) has long asserted that its Durata ICD lead, irrespective of the fact that it is similar in design to the defective Riata leads, is safe for patients. Now, two Wall Street analysts have taken widely contrasting stances related to Durata and the risk it poses for the Minnesota medical device maker. […]